Stone hammer! Two drug companies sell inferior drugs, fine!
Release date: 2019-12-27 Views: 0
Sales of inferior drugs, two drug companies fined!
包头市天芮医药有限责任公司 销售劣药被罚。 On December 24, the Inner Mongolia Drug Administration issued an administrative penalty notice, and Baotou Tianrui Pharmaceutical Co., Ltd. was fined for selling inferior drugs .
On November 26, of the list of 57 batches of unqualified drugs announced by the State Administration of Drug Administration, the "acetyl cysteine solution for inhalation" sold by Baotou Tianrui Pharmaceutical Co., Ltd. was unqualified.
It was verified that the unqualified "acetylcysteine solution for inhalation" was produced by Shanxi Guorun Pharmaceutical Co., Ltd., and the batches operated by Baotou Tianrui Pharmaceutical Co., Ltd. were 181202 and 181204.
- The batch number "181cysteine solution for inhalation" that does not meet the requirements is the inspection item "hydrogen sulfide";
- The "Acetylcysteine solution for inhalation" with lot number 181204 does not meet the requirements. The inspection items are "hydrogen sulfide" and "related substance impurity C".
The Inner Mongolia Medicine Supervision Bureau imposed a fine in accordance with the provisions of Article 74 of the former Drug Administration Law of the People's Republic of China.
新疆九康智远药业有限公司 销售防己等劣药被罚。 On December 21, the Xinjiang Drug Administration issued a notice of administrative penalty, and Xinjiang Jiukang Zhiyuan Pharmaceutical Co., Ltd. was punished for selling inferior drugs such as self-protection.
It was verified that Xinjiang Jiukang Zhiyuan Pharmaceutical Co., Ltd. sold four Chinese medicine decoction pieces, such as Fangji, with batch number 190101, which failed to meet the requirements and should be treated as inferior drugs.
The drug company's behavior violates the provisions of Article 49, paragraph 3, and 6 of the Drug Administration Law of the People's Republic of China, and in accordance with Article 74 of the Drug Administration Law of the People's Republic of China, the following administrative penalty is imposed:
- Confiscated 93 kg of 4 kinds of Chinese medicine decoctions such as Fangji;
- Confiscated illegal income of 7,186 yuan, and imposed a fine of 39,066 yuan twice the value of the illegal drug sales (19533 yuan);
▪ Content Source | Medical Mobile News
- Basic introduction of Heilongjiang Hexiang Pharmaceutical Co., Ltd.
- How to contact Bermuda (Shanghai) Regenerative Medicine Technology Co., Ltd.
- Shandong Dongfang Huiyi Health Industry Co., Ltd.
- Brief introduction of Zaozhuang Yinhai Pharmaceutical Co., Ltd.
- Contact information of Shandong Dongfang Huiyi Health Industry Co., Ltd.
- Brief introduction of Bermudi (Shanghai) Regenerative Medicine Technology Co., Ltd.
- GSK、豪森、恒瑞、信立泰等药企未中选品种主动降价 1. GSK, Haosen, Hengrui, Xinlitai and other pharmaceutical companies have not actively selected prices to reduce prices
- 25省扩围“4+7” 中选企业全分析 2. Full analysis of selected enterprises in the “4 + 7” expansion in 25 provinces
- 2019药企“十大”典型罚单最高8317万 3. The top ten typical fines for pharmaceutical companies in 2019 are 83.17 million
- 三省年底大抽查！ 4. Big spot check at the end of the three provinces! A large number of commonly used drugs were investigated, involving dozens of pharmaceutical companies, all of which were inferior drugs!
- 安徽、江苏省通告，又有53批次药不符合规定 5.Announcements from Anhui and Jiangsu Province, 53 batches of drugs do not meet the requirements
- 卫健委发文连续3年全国考核5类药使用 6. The health and health committee issued a document to assess the use of 5 types of drugs for 3 consecutive years
- 石锤！ 7. Stone Hammer! Two drug companies sell inferior drugs, fine!